Julen Torrens-Baile

ORCID: 0009-0005-5541-6462
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Porphyrin Metabolism and Disorders
  • CRISPR and Genetic Engineering
  • Genetic and Kidney Cyst Diseases
  • Biomedical Research and Pathophysiology
  • Virus-based gene therapy research

Universidad de Navarra
2024

The therapeutic use of adeno-associated viral vector (AAV)-mediated gene disruption using CRISPR-Cas9 is limited by potential off-target modifications and the risk uncontrolled integration genomes into CRISPR-mediated double-strand breaks. To address these concerns, we explored AAV-delivered paired Staphylococcus aureus nickases (D10ASaCas9) to target Hao1 for treatment primary hyperoxaluria type 1 (PH1). Our study demonstrated effective disruption, a significant decrease in glycolate...

10.1038/s44321-023-00008-8 article EN cc-by EMBO Molecular Medicine 2024-01-05
Coming Soon ...